Skip to main content
Top
Published in: Journal of Thrombosis and Thrombolysis 3/2014

01-04-2014

Clinical features in patients with pulmonary embolism at a community hospital: analysis of 4 years of data

Authors: Navin Bajaj, Andrew L. Bozarth, Juan Guillot, Joseph KojoKittah, Sri Ram Appalaneni, Cesar Cestero, Raymond Kofi Amankona, James A. Pippim

Published in: Journal of Thrombosis and Thrombolysis | Issue 3/2014

Login to get access

Abstract

The aim of this study is to assess the various clinical features, risk factors, and electrocardiographic (EKG) findings associated with acute pulmonary embolism (PE). Knowledge gained from the study may enable health care providers in diagnosis of PE, thus allowing them to carry out appropriate diagnostic testing and treatment after recognition of this potentially lethal disease. PE is common but frequently under-diagnosed clinical problem, associated with potentially fatal outcomes. Clinical presentation is highly variable, non-specific and most patients have an underlying identifiable risk factor. The presentation of PE can easily be confused with other cardio-pulmonary or systemic disorders. Prompt diagnosis of this potentially deadly disease is of utmost importance. Knowledge of salient features associated with PE may enable health care providers in diagnosis of PE, thus allowing them to carry out appropriate diagnostic testing and treatment after its recognition. We performed a single-center, cross-sectional descriptive study including all inpatient and emergency department encounters ≥18 years of age diagnosed with PE at our institution, a 300-bed inner city community hospital, during the dates January 2007 to December 2010. All patients were diagnosed with multi-detector 64-slice spiral computed tomography angiography. Using a standardized form, we performed simultaneous retrospective chart review to collect the necessary data required for the study. PE was confirmed in 334 patients during the 4 years study period. Mean age of subjects was 65.8 years (±16.4, range 22–98). Females represented 54 % of study subjects. Dyspnea, chest pain, and cough were present in 72, 38, and 19 % of the patients, respectively. Dyspnea was the only presenting symptom in 29 %. Tachypnea, hypoxia, tachycardia, and signs of DVT were present in 39, 35, 33, and 29 %, respectively. Cancer was most common risk factor present in 27 %, followed by prior history of venous thromboembolism (DVT or PE), immobilization, and surgery in 19, 15, and 15, respectively. EKG interpretation revealed normal sinus rhythm in 53 %, sinus tachycardia in 31 %, S1Q3T3 pattern in 6 %, and atrial fibrillation (AF) in 6 %.We also noted that 8 % of elderly patients had new onset AF at the time of diagnosis of PE. Diagnosis of PE remains a challenging task due to its variable presentation. Many of the classical features associated with this potentially fatal disease are often missing. This data re-emphasizes a wide spectrum of clinical presentation and non-specificity of symptoms of PE. Clinical suspicion of PE is a critical step and of paramount importance for further objective investigations, which would assist in the diagnosis and appropriate timely management of PE.
Literature
1.
2.
go back to reference Anderson FA Jr, Wheeler HB, Goldberg RJ et al (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The worcester DVT study. Arch Intern Med 151:933–938PubMedCrossRef Anderson FA Jr, Wheeler HB, Goldberg RJ et al (1991) A population-based perspective of the hospital incidence and case-fatality rates of deep vein thrombosis and pulmonary embolism. The worcester DVT study. Arch Intern Med 151:933–938PubMedCrossRef
4.
go back to reference Bergqvist D, Fredin H (1991) Pulmonary embolism and mortality in patients with fractured hips–a prospective consecutive series. Eur J Surg 157:571–574PubMed Bergqvist D, Fredin H (1991) Pulmonary embolism and mortality in patients with fractured hips–a prospective consecutive series. Eur J Surg 157:571–574PubMed
5.
go back to reference Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 108:978–981PubMedCrossRef Stein PD, Henry JW (1995) Prevalence of acute pulmonary embolism among patients in a general hospital and at autopsy. Chest 108:978–981PubMedCrossRef
6.
go back to reference Stein PD (2007) Prevalence, risks, and prognosis of pulmonary embolism and deep vein thrombosis. Pulmonary Embolism, 2nd edn. Blackwell, Oxford, pp 3–15 Stein PD (2007) Prevalence, risks, and prognosis of pulmonary embolism and deep vein thrombosis. Pulmonary Embolism, 2nd edn. Blackwell, Oxford, pp 3–15
7.
go back to reference Goldhaber SZ, Hennekens CH, Evans DA et al (1982) Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am J Med 73:822–826PubMedCrossRef Goldhaber SZ, Hennekens CH, Evans DA et al (1982) Factors associated with correct antemortem diagnosis of major pulmonary embolism. Am J Med 73:822–826PubMedCrossRef
8.
go back to reference Modan B, Sharon E, Jelin N (1972) Factors contributing to the incorrect diagnosis of pulmonary embolic disease. Chest 62:388–393PubMedCrossRef Modan B, Sharon E, Jelin N (1972) Factors contributing to the incorrect diagnosis of pulmonary embolic disease. Chest 62:388–393PubMedCrossRef
9.
go back to reference Bergqvist D, Lindblad B (1985) A 30 years survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 72:105–108PubMedCrossRef Bergqvist D, Lindblad B (1985) A 30 years survey of pulmonary embolism verified at autopsy: an analysis of 1274 surgical patients. Br J Surg 72:105–108PubMedCrossRef
10.
go back to reference Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389PubMedCrossRef Goldhaber SZ, Visani L, De Rosa M (1999) Acute pulmonary embolism: clinical outcomes in the International Cooperative Pulmonary Embolism Registry (ICOPER). Lancet 353:1386–1389PubMedCrossRef
11.
go back to reference Nijkeuter M, Söhne M, Tick LW et al (2007) The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study. Chest 131:517–523. doi:10.1378/chest.05-2799 PubMedCrossRef Nijkeuter M, Söhne M, Tick LW et al (2007) The natural course of hemodynamically stable pulmonary embolism: clinical outcome and risk factors in a large prospective cohort study. Chest 131:517–523. doi:10.​1378/​chest.​05-2799 PubMedCrossRef
12.
go back to reference Jerjes-Sanchez Ramírez-Rivera, De Lourdes García M et al (1995) Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 2:227–229PubMed Jerjes-Sanchez Ramírez-Rivera, De Lourdes García M et al (1995) Streptokinase and heparin versus heparin alone in massive pulmonary embolism: a randomized controlled trial. J Thromb Thrombolysis 2:227–229PubMed
13.
go back to reference Torbicki A, Perrier A, Konstantinides S et al (2008) Guidelines on the diagnosis and management of acute pulmonary embolism the task force for the diagnosis and management of acute pulmonary embolism of the european society of cardiology (ESC). Eur Heart J 29:2276–2315. doi:10.1093/eurheartj/ehn310 PubMedCrossRef Torbicki A, Perrier A, Konstantinides S et al (2008) Guidelines on the diagnosis and management of acute pulmonary embolism the task force for the diagnosis and management of acute pulmonary embolism of the european society of cardiology (ESC). Eur Heart J 29:2276–2315. doi:10.​1093/​eurheartj/​ehn310 PubMedCrossRef
16.
go back to reference Stein PD, Terrin ML, Hales CA et al (1991) Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 100:598–603PubMedCrossRef Stein PD, Terrin ML, Hales CA et al (1991) Clinical, laboratory, roentgenographic, and electrocardiographic findings in patients with acute pulmonary embolism and no pre-existing cardiac or pulmonary disease. Chest 100:598–603PubMedCrossRef
19.
go back to reference Palla A, Petruzzelli S, Donnamaria V, Giuntini C (1995) The role of suspicion in the diagnosis of pulmonary embolism. Chest 107:21S–24SPubMedCrossRef Palla A, Petruzzelli S, Donnamaria V, Giuntini C (1995) The role of suspicion in the diagnosis of pulmonary embolism. Chest 107:21S–24SPubMedCrossRef
23.
go back to reference Stein PD, Gottschalk A, Saltzman HA, Terrin ML (1991) Diagnosis of acute pulmonary embolism in the elderly. J Am Coll Cardiol 18:1452–1457PubMedCrossRef Stein PD, Gottschalk A, Saltzman HA, Terrin ML (1991) Diagnosis of acute pulmonary embolism in the elderly. J Am Coll Cardiol 18:1452–1457PubMedCrossRef
25.
go back to reference Hansson PO, Sörbo J, Eriksson H (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 160:769–774PubMedCrossRef Hansson PO, Sörbo J, Eriksson H (2000) Recurrent venous thromboembolism after deep vein thrombosis: incidence and risk factors. Arch Intern Med 160:769–774PubMedCrossRef
Metadata
Title
Clinical features in patients with pulmonary embolism at a community hospital: analysis of 4 years of data
Authors
Navin Bajaj
Andrew L. Bozarth
Juan Guillot
Joseph KojoKittah
Sri Ram Appalaneni
Cesar Cestero
Raymond Kofi Amankona
James A. Pippim
Publication date
01-04-2014
Publisher
Springer US
Published in
Journal of Thrombosis and Thrombolysis / Issue 3/2014
Print ISSN: 0929-5305
Electronic ISSN: 1573-742X
DOI
https://doi.org/10.1007/s11239-013-0942-8

Other articles of this Issue 3/2014

Journal of Thrombosis and Thrombolysis 3/2014 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine